Angela discusses the potential for viruses to evolve resistance to treatments, drawing parallels with influenza. She explains how remdesivir, a nucleoside analog, works by mimicking viral genetic material to disrupt replication and enhance immune response. While promising results have been seen in non-human primates, its efficacy in humans remains to be determined through ongoing clinical trials.
